does tirzepatide cause breast cancer Highlighting 3 ongoing clinical trials of GLP-1 medications in and endometrial cancer. , 1. FITWISE: for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/​HER2 Tirzepatide restricts obesity-related tumor growth

Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been reported to induce weight loss among overweight or obese adults, as well as to have a beneficial effect on cardiometabolic health in these populations (3)

Many patients prescribed Ozempic wonder whether this diabetes medication contains caffeine, particularly if they experience side effects such as nausea or changes in heart rate

Fried fare tends to linger in the digestive system longer, potentially leading to feelings of nausea or gastrointestinal unease

oral research formulations of semaglutide are not standard in the research peptide market and require a substantially more complex preparation than subcutaneous reconstitution

During GLP-1 treatment , contact your GP if you experience: Severe or persistent abdominal pain , particularly if different in character from your usual IBS symptoms or if radiating to your back (which may indicate pancreatitisstop the medication and seek urgent medical attention) Significant worsening of diarrhoea or constipation that doesn't improve with standard measures Persistent nausea or vomiting affecting your ability to maintain adequate nutrition and hydration New symptoms such as rectal bleeding, unintentional weight loss (beyond expected therapeutic effect), or nocturnal symptoms waking you from sleep Difficulty distinguishing between IBS symptoms and medication side effects Sudden pain in the upper right abdomen, fever, or yellowing of the skin/eyes (possible gallbladder diseaseseek urgent medical attention) Red flag symptoms requiring urgent medical attention include: Severe, unremitting abdominal pain Rectal bleeding or black, tarry stools Unexplained weight loss Persistent vomiting with inability to keep fluids down Signs of dehydration Your GP may arrange appropriate investigations such as blood tests (full blood count, inflammatory markers, coeliac serology) or faecal calprotectin testing to distinguish IBS from inflammatory bowel disease where appropriate